4.7 Article

White Matter Reference Region in PET Studies of 11C-Pittsburgh Compound B Uptake: Effects of Age and Amyloid-β Deposition

Journal

JOURNAL OF NUCLEAR MEDICINE
Volume 59, Issue 10, Pages 1583-1589

Publisher

SOC NUCLEAR MEDICINE INC
DOI: 10.2967/jnumed.117.204271

Keywords

AD; C-11-PiB; white matter; amyloid-beta; PET

Funding

  1. NIH [P50 AG16574, U01 AG06786, R01 AG11378, R01 AG041851]
  2. Elsie and Marvin Dekelboum Family Foundation
  3. GHR Foundation
  4. Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program of the Mayo Foundation
  5. GE Healthcare
  6. Siemens Molecular Imaging
  7. AVID Radiopharmaceuticals
  8. Biogen
  9. Lilly Pharmaceuticals
  10. Alzheimer's Disease Cooperative Study

Ask authors/readers for more resources

Amyloid-beta (A beta) deposition as seen on PET using an A beta-binding agent is a critical diagnostic biomarker for Alzheimer disease (AD). Some reports suggest using white matter (WM) as a reference region for quantification of serial A beta PET studies; however, nonspecific WM retention in A beta PET in people with dementia or cognitively unimpaired (CU) has been widely reported and is poorly understood. Methods: To investigate the suitability of WM as a reference region and the factors affecting WM C-11-Pittsburgh compound B (C-11-PiB) uptake variability, we conducted a retrospective study on 2 large datasets: a longitudinal study of participants (n 5 577) who were CU, had mild cognitive impairment, or had dementia likely due to AD; and a crosssectional study of single-scan PET imaging in CU subjects (n 5 1,349). In the longitudinal study, annual changes in WM C-11-PiB uptake were assessed, and in the cross-sectional study, WM C-11-PiB uptake was assessed relative to subject age. Results: Overall, we found that WM C-11-PiB uptake showed age-related increases, which varied with the WM regions selected. Further, variable annual WM C-11-PiB uptake changes were seen with different gray matter (GM) C-11-PiB baseline uptake levels. Conclusion: WM binding increases with age and varies with GM C-11-PiB. These correlations should be considered when using WM for normalization in C-11-PiB PET studies. The cerebellar crus(11)crus2 showed no increase with age and cerebellar GM1WM showed minimal increase, supporting their use as reference regions for cross-sectional studies comparing wide age spans. In longitudinal studies, the increase in WM uptake may be minimal in the short-term and thus using WM as a reference region in these studies seems reasonable. However, as participants age, the findings may be affected by changes in WM uptake. Changes in WM C-11-PiB uptake may relate to disease progression, warranting examination of the causes of WM C-11-PiB uptake.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available